2013 Publications supported by the Fungal Infection Trust directly or indirectly

Al-Shair K, Atherton G, Harris C, Ratcliffe L, Newton P & Denning DW. (2013). Long-term Antifungal Treatment Improves Health Status in Patients With Chronic Pulmonary Aspergillosis: A Longitudinal Analysis. Clin Infect Dis, 57(6):828-35

Al-shair K, Atherton GT, Kennedy D, Powell G, Denning DW & Caress A. (2013). Validity and reliability of the St. George’s Respiratory Questionnaire in assessing health status in patients with chronic pulmonary aspergillosis. Chest, 144(2):623-31

Barrs VR, van Doorn TM, Houbraken J, Kidd SE, Martin P, Pinheiro MD, Richardson MD, Varga J & Samson RA. (2013). Aspergillus felis sp.nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PLoS ONE, 8(6):e64871

Baxter C, Denning DW, Jones A, Todd A, Moore C & Richardson MD. (2013). Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin Microbiol Infect, 19(4):E197-204

Baxter C, Moore C, Jones A, Webb A & Denning DW (2013). IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest, 143(5):1351-7

Baxter C, Dunn G, Jones A, Webb K, Gore R, Richardson M & Denning DW. (2013). Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol, 132(3):560-566

Buied A, Moore C, Denning DW & Bowyer P. (2013). High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates. J Antimicrob Chemother, 68(3):512-4.

Denning DW, Pleuvry A & Cole D. (2013). Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol, 51(4):361-70

Denning DW, Pleuvry A & Cole D. (2013). Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J, 41(3):621-6

Farid S, Mohamed S, Devbhandari M, Kneale M, Richardson M, Soon SY, Jones MT, Krysiak P, Shah R, Denning DW & Rammohan K. (2013). Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence – a National Centre’s experience. J Cardiothoracic Surgery, 8(1):180.

Fraczek M, Bromley M, Buied A, Moore C, Rajendran R, Rautemaa R, Ramage G, Denning DW & Bowyer P. (2013). The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother, 68(7):1486-96.

Gregson L, Goodwin J, Johnson A, McEntee L, Moore CB, Richardson M, Hope WW & Howard SJ. (2013). In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole. Antimicrob Agents Chemother, 57(11):5778-5780

Grice C, Bertuzzi M & Bignell E (2013). Receptor-mediated signaling in Aspergillus fumigatus. Front Microbiol, 4:26.

Howard S, Pasqualotto A, Anderson M, Leatherbarrow H, Albarrag A, Harrison E, Gregson L, Bowyer P & Denning DW. (2013). Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis. Mycoses, 56(4):434-41